Annette is redefining metabolic and obesity care in Europe with a medical, data-driven and deeply human model, addressing one of the most urgent health challenges of our time.

Obesity is a chronic condition, yet access to safe, supervised and effective care remains limited. Annette changes that. Their model combines physician-led treatment, GLP-1 protocols, continuous monitoring and long-term behavioural support within a single, seamless experience.

Why Clover invested:

• A clinically robust, medically supervised pathway designed for outcomes.

• A tech-enabled platform that delivers personalised, sustainable support at scale.

• A care model that restores dignity, accessibility and long-term impact to patients.

• A solution aligned with the Future of Work & health of work: as employers take a growing role in health and well-being, structured metabolic care becomes essential to workforce resilience and performance.

We’re excited to support Francois-Xavier TRANCART, Gwen Le Calvez and the entire Annette team as they build the future of obesity care, accessible, safe and genuinely transformative.